Ovid Therapeutics

OVID

Capitalización de mercado USD 479 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Takeda Pharmaceutical Company Tokyo, Japan	USD 2.49 M	–	–	–
2	2 BVF Inc San Francisco, California	USD 1.27 M	–	–	–
3	3 Vanguard Group Malvern, Pennsylvania	USD 870 k	-USD 142 k	-472,666	-15%
4	4 Sio Capital Management New York	USD 736 k	–	–	–
5	5 Acadian Asset Management Boston, Massachusetts	USD 693 k	+USD 6.11 k	+20,290	+1%
6	6 Renaissance Technologies New York	USD 691 k	+USD 323 k	+1,071,509	+105%
7	7 Kennedy Capital Management St Louis, Missouri	USD 496 k	-USD 69.5 k	-230,536	-13%
8	8 Driehaus Capital Management Chicago, Illinois	USD 462 k	–	–	–
9	9 BlackRock New York	USD 452 k	-USD 750 k	-2,490,572	-65%
10	10 Madison Avenue Partners New York	USD 433 k	-USD 348 k	-1,154,261	-47%
11	11 Adage Capital Partners Boston, Massachusetts	USD 379 k	–	–	–
12	12 Millennium Management New York	USD 347 k	+USD 317 k	+1,052,334	Nuevas
13	13 Wells Fargo San Francisco, California	USD 252 k	-USD 7.06 k	-23,433	-3%
14	14 GSA Capital Partners London, United Kingdom	USD 245 k	+USD 91 k	+302,087	+69%
15	TA 15 TLS Advisors Miami, Florida	USD 225 k	–	–	–
16	16 Affinity Asset Advisors New York	USD 220 k	–	–	–
17	17 Geode Capital Management Boston, Massachusetts	USD 212 k	-USD 207 k	-687,658	-52%
18	18 Rosalind Advisors Toronto, Ontario, Canada	USD 165 k	+USD 151 k	+500,000	Nuevas
19	19 Rubric Capital Management (New York) New York	USD 158 k	-USD 1.46 M	-4,837,436	-91%
20	20 Assenagon Asset Management Senningerberg, Luxembourg	USD 144 k	-USD 37.7 k	-125,210	-22%
21	21 Goldman Sachs New York	USD 93.6 k	+USD 54 k	+179,389	+172%
22	22 Susquehanna International Group Bala Cynwyd, Pennsylvania	USD 76 k	+USD 44.3 k	+147,161	+177%
23	23 State Street Boston, Massachusetts	USD 74.9 k	-USD 345 k	-1,145,075	-83%
24	24 Squarepoint New York	USD 72.9 k	-USD 13.4 k	-44,365	-17%
25	25 Marshall Wace London, United Kingdom	USD 54.4 k	+USD 49.6 k	+164,721	Nuevas

Ovid Therapeutics OVID Capitalización de mercado USD 479 M

Ovid Therapeutics

OVID

Capitalización de mercado USD 479 M